CEO Speaks: On the major milestone for Biocon-Sandoz and how this collaboration will enable Biocon to address the next wave of Global Biosimilar Opportunities!
First Biosimilar Trastuzumab approved in the US
Mr. Suresh Subramanian, Senior Vice President & Head Branded Formulations, Biocon shares his views on how KRABEVA® can make a significant impact in the biosimilars space.
Mental health is one of the biggest issues facing our society today. Stress at the workplace is unavoidable. Here are a few simple strategies that can not only help you do your job better but also improve facets of your personal life.
Prasad Deshpande, Vice President & Head, SCM, Biocon shares his views on the impact of GST on Supply Chain in Pharma Sector.
Seema Ahuja, VP & Global Head of Communications, Biocon speaks on Healthcare PR, key challenges faced by the Healthcare and Pharma businesses & how in-house communication teams manage and navigate regulatory issues.
BIOCON is awarded the “9th NATIONAL IPR AWARD FOR 2017” in the category “Top Indian Company for creating Global Brand” & also conferred with “WIPO USERS TROPHY”
Kiran Mazumdar-Shaw shares her views on how #digitalindia can transform lives, boost growth & propel us to double digit growth.
Arshad Jamil, General Manager, IPR, Biocon talks about Biocon's IP strategy that is creating value by leveraging the potential of our innovative products & processes.
Kiran Mazumdar Shaw, CMD, Biocon shares her views on #Budget2017